Sign in
CompletedNo phase

Prevalence of Postpartum Depression Among Patients of the CHUM GARE Clinic

Key facts

Who runs it
Centre hospitalier de l'Université de Montréal (CHUM)
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
100 people enrolled
Started
20 Oct 2025
Ended
1 Apr 2026
Type of study
Observational
Record updated
6 July 2026

Who can take part

Age
18 years and older
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Patients aged 18 years or more
  • Patient who gave birth within the last 4 weeks to 6 months
  • Ability to understand French or English and complete the EPDS questionnaire
  • Physically present at their post-partum visit at the clinic

Who cannot take part

  • Inability to comprehend and/or complete the EPDS
  • Declines participation or does not provide informed consent

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Postpartum depression (PPD) is a frequent complication of the postnatal period but remains underdetected in routine clinical practice. This prospective clinical study, conducted at the high-risk pregnancy clinic of the CHUM, aims to estimate the prevalence of PPD among patients seen in postpartum follow-up. It also assesses the feasibility of implementing a standardized screening protocol that combines the administration of the Edinburgh Postnatal Depression Scale (EPDS) with a clinical decision-support algorithm to guide appropriate medical follow-up. The study also seeks to explore clinical characteristics associated with higher EPDS scores.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
6 July 2026